ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 300

Proliferative Globular Synovitis, an Ultrasound Pattern Associated with Seropositive Rheumatoid Arthritis

Ana Belén Azuaga-Piñango1, Beatriz Frade-Sosa 2, Roberto Gumucio 3, Katherine Cajiao-Sanchez 2, Stanislava Mandelikova 2, Virginia Ruiz-Esquide 4, Raul Castellanos-Moreira 2, Raimon Sanmarti 5, Juan Cañete 5 and Julio Ramirez 1, 1Hospital Clinic, Barcelona, Spain, Barcelona, Spain, 2Hospital Clinic, Barcelona, Spain, Barcelona, Catalonia, Spain, 3Rheumatology Department. Hospital Clínic Barcelona, Barcelona, Catalonia, Spain, 4Department of Rheumatology, Hospital Clínic, Barcelona, Barcelona, Catalonia, Spain, 5Department of Rheumatology, Hospital Clínic, Barcelona, Barcelona, Spain

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Rheumatoid arthritis (RA), ultrasonography and synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Imaging Of Rheumatic Diseases Poster I

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid Arthritis (RA) has a synovial ultrasound (US) pattern, while soft tissue involvement is more frequently found in Psoriatic Arthritis (PsA). No previous studies have analyzed if US findings differ between seropositive and seronegative RA patients. The objective is to analyze differences in the ultrasound pattern among patients with seropositive and seronegative RA.  To assess if proliferative globular synovitis is associated to seropositive RA.

Methods: Retrospective Analysis. We collected clinical, epidemiological and ultrasound images of patients with RA who met ACR/EULAR 2010 criteria with bilateral carpal and hand ultrasonography carried out during the last five years. Synovial hypertrophy (SH) and Power Doppler signal (PD) in wrist and 1-5 metacarpophalangeal (MCP) were evaluated. We calculated the SH score  (sum of the SH degrees of each joint), PD (sum of the PD degrees of each joint) and the total score (sum of the score of SH and PD) for each patient.  We also evaluated the presence of proliferative globular synovitis, defined as big synovial hypertrophy with exophytic growth and a convex upper limit

Results: 145 RA patients were collected. 80% were women. Mean age was 59.06 (14.8) years and the mean time of disease evolution was 114.6 (112.8) months. 68.3% were RF positive and 74.5% ACPA positive. Overall, 115 of the 145 (79.3%) patients were seropositive for RF/ACPA. 53.1% had radiographic erosions, 73.1% used conventional synthetic Disease-modifying drugs (DMARDs), 29.7% biological therapy, and 57.2% low doses of corticosteroids (< 5 mg prednisone). The mean DAS28 was 2.81 (1.14), the number of swollen joints was 3 (3.4), and CRP was 0.99 mg/dl (1.6). No significant differences between seropositive and seronegative patients in terms of disease activity (swollen joints count [SJC], tender joint count [TJC], CRP, DAS28), treatment (use of corticosteroids, DMARDs, biological), time of evolution or US scores (SH, PD and total scores) were found. Globular synovitis was present in 71 patients 61.7% and 10.3%  (62% and 13.7%) of seropositive and seronegative RA patients, respectively (p< 0.0001). Globally, 75 (51.7%) out of 145 patients had “globular” synovitis by US (Figure 1). 71 out of 75 patients were FR /ACPA positive (95.9%). Only three patients with seronegative RA had this US pattern (p < 0.001). Furthermore, patients with “globular” synovitis had more erosions (72% vs 32.9%, p 0.000), higher SJC (3.3and higher SH and PD scores (p< 0.001).

Conclusion: The presence of proliferative globular synovitis was significantly associated with the presence of RF/ ACPA in patients with RA. This US pattern identified a subgroup of RA patients with poor prognosis:  more erosions and greater inflammatory activity both at clinical and ultrasound level.

Globular synovitis in MCP joint of a FR and ACPA positive RA patient. The synovial has an exophytic growth with globular shape and convexity in the upper limit of joint capsule.

Synovitis in MCP joint of a patient with FR and ACPA negative RA. Synovial proliferation is low and the upper limit of the joint capsule has a flat shape.


Disclosure: A. Azuaga-Piñango, None; B. Frade-Sosa, None; R. Gumucio, None; K. Cajiao-Sanchez, None; S. Mandelikova, None; V. Ruiz-Esquide, None; R. Castellanos-Moreira, None; R. Sanmarti, None; J. Cañete, Eli Lilly and Company, 5, Janssen, 5, 8, Novartis, 5, 8, Mylan, 5, Pfizer, 5, UCB, 5; J. Ramirez, None.

To cite this abstract in AMA style:

Azuaga-Piñango A, Frade-Sosa B, Gumucio R, Cajiao-Sanchez K, Mandelikova S, Ruiz-Esquide V, Castellanos-Moreira R, Sanmarti R, Cañete J, Ramirez J. Proliferative Globular Synovitis, an Ultrasound Pattern Associated with Seropositive Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/proliferative-globular-synovitis-an-ultrasound-pattern-associated-with-seropositive-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/proliferative-globular-synovitis-an-ultrasound-pattern-associated-with-seropositive-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology